Wockhardt gets USFDA nod for Bethanechol
Wockhardt Ltd has said that it has received USFDA approval for marketing bethanecol chloride tablets in the US. The tablets will be marketed in the US through a strategic alliance with Ranbaxy
Wockhardt Ltd has said that it has received USFDA approval for marketing bethanecol chloride tablets in the US. The tablets will be marketed in the US through a strategic alliance with Ranbaxy